StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Up 0.7 %
Shares of AEZS stock opened at $3.79 on Tuesday. The business has a fifty day simple moving average of $4.50 and a 200 day simple moving average of $6.14. The company has a market cap of $6.80 million, a P/E ratio of -0.26 and a beta of 1.55. Aeterna Zentaris has a twelve month low of $3.96 and a twelve month high of $12.00.
About Aeterna Zentaris
Further Reading
- Five stocks we like better than Aeterna Zentaris
- Trading Halts Explained
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Retail Stocks Investing, Explained
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Stock Market Upgrades: What Are They?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.